-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
in China.
After Agilent fired the first shot of the "localization" process of instrument foreign companies in 2022, Watts, ILLUMINA, Thermo Fisher, Shimadzu and other instrument foreign companies have also accelerated their actions, laid out the investment industry chain in China, and deepened the localization strategy
.
.
In recent years, China's scientific and technological development has made great achievements, manned space technology has created a number of "firsts", China's first solar exploration science and technology experiment satellite "Xihe" successfully launched, artificial intelligence, Chang'e "moon sweeping.
.
.
A series of major innovations are emerging
.
China's scientific and technological strength has moved from quantitative accumulation to qualitative leap
.
Statistics show that China's global innovation index ranking rose to eleventh place
in 2022.
All this marks the progress of
China's scientific and technological strength.
.
.
A series of major innovations are emerging
.
China's scientific and technological strength has moved from quantitative accumulation to qualitative leap
.
Statistics show that China's global innovation index ranking rose to eleventh place
in 2022.
All this marks the progress of
China's scientific and technological strength.
Instruments are an important prerequisite and fundamental guarantee
for the development of science and technology.
The development of science and technology has also promoted the development and progress
of the instrument industry.
With the improvement of China's scientific and technological development level, in recent years, the demand for China's instrument market has been expanding, and business opportunities have continued to grow
.
In addition, in the international market environment, the importance of the Chinese market is also increasing
.
At the same time, in order to further increase the investment attraction of manufacturing industry and promote the high-quality development of the use of foreign capital, China has issued a series of policies such as "Several Policies and Measures on Promoting the Expansion of Foreign Investment with a Focus on Manufacturing, Stabilizing Stock and Improving Quality", "Catalogue of Industries Encouraging Foreign Investment (2022 Edition)", etc.
, and the foreign investment environment is favorable
.
Under the combined effect of various factors, many foreign-funded scientific instrument enterprises have increased investment in China to promote the development
of enterprise localization process.
for the development of science and technology.
The development of science and technology has also promoted the development and progress
of the instrument industry.
With the improvement of China's scientific and technological development level, in recent years, the demand for China's instrument market has been expanding, and business opportunities have continued to grow
.
In addition, in the international market environment, the importance of the Chinese market is also increasing
.
At the same time, in order to further increase the investment attraction of manufacturing industry and promote the high-quality development of the use of foreign capital, China has issued a series of policies such as "Several Policies and Measures on Promoting the Expansion of Foreign Investment with a Focus on Manufacturing, Stabilizing Stock and Improving Quality", "Catalogue of Industries Encouraging Foreign Investment (2022 Edition)", etc.
, and the foreign investment environment is favorable
.
Under the combined effect of various factors, many foreign-funded scientific instrument enterprises have increased investment in China to promote the development
of enterprise localization process.
Chemical Instrument Network sorted out the localization strategic layout of some foreign-funded enterprises in 2022, including opening new factories, establishing science and technology innovation centers, and reaching strategic cooperation with local enterprises
.
(Special statement: limited by time and resources, this inventory is incomplete statistics, if there is any omission, welcome to supplement and improve)
.
(Special statement: limited by time and resources, this inventory is incomplete statistics, if there is any omission, welcome to supplement and improve)
Agilent Announces Expansion of Production and Capacity at Shanghai Manufacturing Center: On January 7, 2022, Agilent announced that it will expand production and capacity at its Shanghai Manufacturing Center, investing in scaling up production of advanced technology products such as liquid chromatograph (LC), spectrometer, and mass spectrometer (MS) systems, and further enhancing Agilent's manufacturing capabilities
in China.
in China.
Danaher Life Sciences Guangdong-Hong Kong-Macao Greater Bay Area Headquarters unveiled: On March 3, 2022, Danaher Life Sciences Guangdong-Hong Kong-Macao Greater Bay Area Headquarters was officially inaugurated on Guangzhou Bio Island, and Danaher China Life Sciences Research Institute Guangzhou Applied R&D Center was also opened
.
The headquarters takes Guangzhou Bio Island as the core, radiates South China, and empowers the development and upgrading
of China's pharmaceutical industry.
.
The headquarters takes Guangzhou Bio Island as the core, radiates South China, and empowers the development and upgrading
of China's pharmaceutical industry.
Beckman Coulter and Liho Biologics signed a strategic cooperation: In March 2022, Beckman Coulter, a medical diagnostic company owned by Danaher, signed a strategic cooperation agreement with Liho Biologics, and the two parties will carry out multi-faceted cooperation in the field of immunodetection, jointly create more complete and higher-quality diagnostic solutions for the local market, improve the accessibility of high-quality medical services, and then benefit more domestic patients
.
.
Waters Greater China Headquarters Officially Opens in Shanghai: In July 2022, Waters Greater China Headquarters officially opened in Shanghai, and classic products were made in China at the end of the year
.
.
Shimadzu Mass Spectrometry Product Line Settled in China: On August 18, 2022, Shimadzu Suzhou Plant introduced more models such as spectroscopy, chromatography, and mass spectrometry to promote higher performance models to be produced at the Suzhou Plant, and the mass spectrometry product line settled in China, which is a milestone event
in the localization process of Shimadzu Suzhou Plant.
in the localization process of Shimadzu Suzhou Plant.
Illumina officially opened its first manufacturing base in China: In August 2022, Illumina officially opened its first manufacturing base in China in Shanghai, and plans to gradually achieve full localization of
high-end gene sequencers and consumables in the next five years.
The total investment of the first phase of the project is nearly 50 million yuan, and the company plans to invest more than 450 million yuan in the next five years to build production and manufacturing capacity
in China.
high-end gene sequencers and consumables in the next five years.
The total investment of the first phase of the project is nearly 50 million yuan, and the company plans to invest more than 450 million yuan in the next five years to build production and manufacturing capacity
in China.
Waters and China Science and Technology New Life Deepen Collaboration: On August 25, 2022, Waters Corporation and Shanghai Zhongke New Life Biotechnology Co.
, Ltd.
("Zhongke New Life") entered into an application technology partnership to optimize the upstream process development process of biopharmaceuticals, accelerate the efficiency and improve the accuracy
of bioprocess development.
, Ltd.
("Zhongke New Life") entered into an application technology partnership to optimize the upstream process development process of biopharmaceuticals, accelerate the efficiency and improve the accuracy
of bioprocess development.
Agilent and Pinson Medical Collaborate to Establish Innovation Center: On September 16, 2022, Agilent announced that it and Pinsen Medical will continue to deepen their strategic cooperation and establish the "Agilent-Pinson Medical China Precision Medicine Innovation Center", the two parties will strengthen comprehensive cooperation in the development and application of clinical mass spectrometry technology, jointly support the research and development of medical institutions and third-party testing institutions, empower China's clinical mass spectrometry application ecology, and help the continuous innovation
of precision medicine.
of precision medicine.
Thermo Fisher Scientific invests in Guangdong-Hong Kong-Macao Greater Bay Area base in Guangzhou: On September 20, 2022, Thermo Fisher Scientific announced that it has signed a cooperation agreement with the Guangzhou Economic and Technological Development Zone Management Committee to invest in the establishment of Thermo Fisher Scientific Guangdong-Hong Kong-Macao Greater Bay Area Base
in Guangzhou Development Zone, Huangpu District, Guangzhou.
Construction of the site is scheduled to begin in the third quarter of 2022 and is expected to be completed and put into operation
in 2023.
in Guangzhou Development Zone, Huangpu District, Guangzhou.
Construction of the site is scheduled to begin in the third quarter of 2022 and is expected to be completed and put into operation
in 2023.
Merck opens its first biosafety testing laboratory in China: On September 21, 2022, Merck established the "Merck China Biosafety Testing Experimental Center" in Zhangjiang, Shanghai, with a total investment of 29 million euros and covering an area of 5,000 square meters, which is Merck's first biosafety testing laboratory
in China.
in China.
Shimadzu and Jiangnan University Future Food Science Center jointly build a cooperative laboratory: On October 14, 2022, the Shimadzu Advanced User Exchange and the Jiangnan University Future Food Science Center-Shimadzu Cooperation Laboratory Signing Conference were successfully held
in Wuxi.
in Wuxi.
ZEISS invests 170 million yuan in Suzhou to build a new R&D and production base: On October 18, 2022, ZEISS invested 170 million yuan in Suzhou Industrial Park to lay the foundation stone for the construction of a new R&D and production base, providing localized R&D and production services for its industrial quality, research microscope, surgical microscope, ophthalmic equipment and other business departments, which is ZEISS' first land purchase and self-construction project
in China.
in China.
New Opening of Sartorius North China Customer Application and Innovation Center: On November 1, 2022, Sartorius announced the official opening of the North China Customer Application and Innovation Center
.
Located in Yantai, Shandong Province, the center will simplify and accelerate the development of
life sciences and bioprocesses.
.
Located in Yantai, Shandong Province, the center will simplify and accelerate the development of
life sciences and bioprocesses.
Situofan announces a capital increase of 60 million yuan to build a China science and technology innovation center: On November 5, 2022, Situofan announced that it will increase its capital by 60 million yuan to build a China science and technology innovation center in China, and release localized new products to accelerate the innovation and high-quality development
of the local biopharmaceutical industry.
of the local biopharmaceutical industry.
Merck announces partnership with Purmes: On November 7, 2022, Merck announced a partnership
with Purmeis Biotechnology (Zhuhai) Co.
, Ltd.
("Purmes").
with Purmeis Biotechnology (Zhuhai) Co.
, Ltd.
("Purmes").
Agilent and Baichen Medical Reach Strategic Partnership: On December 9, 2022, Agilent announced a strategic partnership with biotechnology company Zhejiang Baichen Medical Technology Co.
, Ltd.
to jointly provide advanced clinical testing and diagnostic solutions for the domestic market, with a focus on improving clinical testing practices, disease prevention, screening, and treatment
.
, Ltd.
to jointly provide advanced clinical testing and diagnostic solutions for the domestic market, with a focus on improving clinical testing practices, disease prevention, screening, and treatment
.
Thermo Fisher Scientific to Open New Plant in Hangzhou, China: On December 8, 2022, Thermo Fisher Scientific announced that it will open a new facility in Hangzhou, China, to help pharmaceutical and biotech customers get treatments to patients faster
.
At the same time, the site can also meet the needs
of organizations in China and neighboring countries for biologics and aseptic products development and manufacturing capabilities in the Asia-Pacific region.
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body). .
At the same time, the site can also meet the needs
of organizations in China and neighboring countries for biologics and aseptic products development and manufacturing capabilities in the Asia-Pacific region.
appendChild(createElement('script')).
src='http://bdimg.
share.
baidu.
com/static/api/js/share.
js?v=89860593.
js?cdnversion='+~(-new Date()/36e5)];
